| Product Unit Size | Cost | Quantity | Stock |
|---|
Vinorelbine is a semi-synthetic vinca alkaloid originally found in Catharanthus that exhibits anticancer chemotherapeutic activity. Vinorelbine binds β-tubulin and stimulates microtubule depolymerization, acting as an anti-mitotic. Vinorelbine is clinically used to treat breast cancer and non-small cell lung cancer (NSCLC). In osteosarcoma cells, vinorelbine downregulates expression of cyclin D1 and upregulates expression of p53, inhibiting cell growth.
| Cas No. | 71486-22-1 |
|---|---|
| Purity | ≥90% |
| Formula | C45H54N4O8 |
| Formula Wt. | 778.93 |
| Chemical Name | 3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine |
| Synonym | Vinorelbine, NavelbineR, KW 2307, nor-5'-anhydrovinblastine, NVB |
| Appearance | Light brown powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Capasso A. Vinorelbine in cancer therapy. Curr Drug Targets. 2012 Jul;13(8):1065-71. PMID: 22594474.
Roncuzzi L, Marti G, Baiocchi D, et al. Effect of Vinorelbine on cell growth and apoptosis induction in human osteosarcoma in vitro. Oncol Rep. 2006 Jan;15(1):73-7. PMID: 16328036.
